KCNH2 Antikörper (AA 1001-1159) (Cy7)
Kurzübersicht für KCNH2 Antikörper (AA 1001-1159) (Cy7) (ABIN734849)
Target
Alle KCNH2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1001-1159
-
Kreuzreaktivität
- Human, Ratte
-
Homologie
- Mouse,Dog,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human HERG
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- FCM 1:20-100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- KCNH2 (Potassium Voltage-Gated Channel, Subfamily H (Eag-Related), Member 2 (KCNH2))
-
Andere Bezeichnung
- Kcnh2
-
Hintergrund
-
Synonyms: ERG1, HERG, LQT2, SQT1, ERG-1, H-ERG, HERG1, Kv11.1, Potassium voltage-gated channel subfamily H member 2, Eag homolog, Ether-a-go-go-related gene potassium channel 1, Eag-related protein 1, Ether-a-go-go-related protein 1, hERG-1, Voltage-gated potassium channel subunit Kv11.1, KCNH2, ERG
Background: Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel. Channel properties are modulated by cAMP and subunit assembly. Mediates the rapidly activating component of the delayed rectifying potassium current in heart (IKr). Isoforms USO have no channel activity by themself, but modulates channel characteristics by forming heterotetramers with other isoforms which are retained intracellularly and undergo ubiquitin-dependent degradation.
-
Gen-ID
- 3757
-
UniProt
- Q12809
Target
-